Back

Transferrin saturation is a superior prognostic biomarker for iron deficiency after acute decompensated heart failure: a retrospective clinical real-world cohort study

1 September 2024 (15:00 - 15:50)
Organised by: Logo
Congress Presentation Part of: Cardiac and extracardiac comorbidities in heart failure Comorbidities ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Jonathan Johansson

Institute of Medicine - Sahlgrenska Academy - University of Gothenburg, Gothenburg (Sweden)

8 More presentations in this session

Presentation thumbnail
Outcomes of bariatric surgery in obese patients with heart failure:a meta-analysis
Doctor H. Ahmed (Omaha, US)
Abstract Slides Video
Presentation thumbnail
Quality of muscle in the thigh predicts the prognosis in patients with non-ischemic cardiomyopathy.
Doctor T. Yoshida (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Phenotype groups in atrial cardiomyopathy and their prognosis
Doctor R. Ilieva (Sofia, BG)
Abstract Slides Video
Presentation thumbnail
An Elevated FIB-4 Score is associated with the severity of heart failure
Professor A. Bielecka-Dabrowa (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
The underestimated risk of prediabetes on cardiovascular outcomes in heart failure with reduced left ventricular function
Doctor A. Hammer (Vienna, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac and extracardiac comorbidities in heart failure

The Event

Event poster

ESC Congress 2024

1 September 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Assessment of biomarkers for iron deficiency following acute decompensated heart failure and its outcomes: a retrospective real-world clinical cohort study
thumbnail
Congress Presentation
Low serum iron and transferrin saturation are associated with new-onset heart failure
thumbnail
Congress Presentation
Associations of different definitions of iron deficiency with cardiac structure and function, congestion, exercise capacity and prognosis in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources